|
American Academy of Ophthalmology Web Site: www.aao.org
|
||
|
Products & Services |
||
|
|
||
| |
||
|
• Retina Tomograph
The portable, laptop-based HRT3 uses laser technology to produce a topographical image of a patient’s optic nerve, providing analysis of the structure’s cup, rim and retinal nerve fiber layer. The device eliminates the need to draw contour lines or use reference planes. It also provides real-time feedback to the operator to aid in acquiring a good quality image. The tomograph features the Fast Check Glaucoma Probability Score, which provides statistical probability of glaucoma using ethnic-specific databases. The HRT3 monitors a patient’s condition over time, comparing baseline images to follow-up examinations and highlighting areas of statistically significant progression.
Advanced Medical Optics has received FDA approval to market the Star S4 IR Excimer Laser System with the Custom- Vue procedure to treat high myopia and myopic astigmatism. Indications include the reduction or elimination of myopia and myopic astigmatism from –6 D to –11 D with up to –3 D of cylinder. The CustomVue procedure uses the WaveScan WaveFront System, which is designed to capture a comprehensive “fingerprint” of each eye and generate an individualized treatment for each procedure.
The A-Plus immersion-capable A-Scan has been introduced by Accutome. The A-Plus has the ability to measure different eye types, including those with dense cataracts and those filled with silicone oil. According to Accutome, the A-Plus meets the challenge of post-refractive patients by including software for the Double K, Shammas Clinical and Clinical History methods. The device can display IOL calculations in 0.25-D increments. The company states the device can also evolve with future biometry demands through its eye-type adjustability, independent velocities and IOL material features. The A-Plus contains storage for 100 patient records and 45 different IOLs. Information, including full waveform data, can be downloaded to a PC. PediaVision has introduced the SO4 vision screener, an infrared, simultaneous binocular videoretinoscopy device. The screener measures refraction, pupil size and gaze deviation in just one to three seconds from a distance of 1 meter to minimize accommodation. This device can be used in patients as young as six months. It provides instant results with automated interpretation, including a printable certificate indicating a pass or fail score that can be used for vision screening exams and determination of amblyogenic factors.
The FDA has approved Allergan’s Alphagan P (brimonidine tartrate ophthalmic solution) 0.1 percent. It is indicated for the lowering of IOP in patients with open-angle glaucoma or ocular hypertension. The company reports that Alphagan P 0.1 percent was developed to further minimize drug exposure while maintaining the drug’s favorable efficacy profile.
FCI Ophthalmics introduces the ProLong Plug, designed to provide patient comfort from dry eye for three months or more. The company reports that these long-term temporary plugs are effective for treatment of transient dry eye after surgery and postoperative dry eye management of LASIK patients.
|
||
Copyright © 2013 American Academy of Ophthalmology
